Publications

X. Wang, W. Liu, B. Yin, P. Yu, X. Duan, Z. Liao, C. Liu, Y. Sang, G. Zhang, Y. Chen, Z. Tao*. Colorimetric detection of gene transcript by target-induced three-way junction formation. Talanta. 2016; 158:1-5.

Y. Cheng, P. Yu, X. Duan, C. Liu, S. Xu, Y. Chen, Y. Tan, Y. Qiang, J. Shen, Z. Tao*. Genome-wide analysis of androgen receptor binding sites in prostate cancer cells. Exp Ther Med. 2015; 9(6): 2319-2324.

M. Shen, X. Duan, P. Zhou, W. Zhou, X. Wu, S. Xu, Y. Chen, Z. Tao*. Lymphotoxin beta receptor activation promotes bladder cancer in a nuclear factor-kappaB-dependent manner. Mol Med Rep. 2015; 11(2): 783-90.

S. Yu, H. Huang, G. Deng, Z. Xie, Y. Ye, R. Guo, X. Cai, J. Hong, D. Qian, X. Zhou, Z. Tao*, B. Chen, Q. Li. miR-326 targets antiapoptotic Bcl-xL and mediates apoptosis in human platelets. PLoS One. 2015; 10(4): e0122784.

W. Zhou, Z. Tao*, Z. Wang, W. Hu, M. Shen, L. Zhou, Z. Wen, Z. Yu, X. Wu, K. Huang, Y. Hu, X. Lin. Long noncoding RNA PCA3 gene promoter region is related to the risk of prostate cancer on Chinese males. Exp Mol Pathol. 2014; 97(3): 550-3.

Z. Liaoa, H. Tang, Y. Xie, X. Duan, S. Xua, C. Liua, Y. Chenga, Y. Chen, Y. Tan, D. Wang, M. Luo, Z. Tao*. Fibrinogen Hangzhou: congenital dysfibrinogenemia caused by the novel missense mutation in FGG (gamma308Asn-->Thr). Clin Chim Acta. 2013; 106-109.

Y. H. Chen, S. Q. Wang, X. L. Wu, M. Shen, Z. G. Chen, X. G. Chen, Y. X. Liu, X. L. Zhu, F. Guo, X. Z. Duan, X. C. Han, Z. H. Tao*. Characterization of microRNAs expression profiling in one group of Chinese urothelial cell carcinoma identified by Solexa sequencing. Urol Oncol. 2013; 31(2): 219-27.